Pfizer Inc. (0Q1N)
LSE
Real-time Data
07:00 AM
Day's Range
27.6352 wk Range
21.83Overview - 0Q1N - Pfizer Inc.
Key Statistics
Valuation
Enterprise Value
195.62B
P/E (Trailing)
‪6.27‬
PEG Ratio
‪-0.05‬
Price / Sales (TTM)
‪1.83‬
Price / Book
‪1.34‬
EV / EBITDA
‪6.29‬
Profitability
Gross Margin
‪72.78%‬
Profit Margin
‪27.55%‬
Operating Margin
‪32.52%‬
Return on Assets
‪7.62%‬
Return on Equity
‪23.06%‬
Ownership
Shares Outstanding
5.69B
Float
5.64B
Held by Insiders
‪0.04%‬
Held by Institutions
‪70.76%‬
Price stats
Beta
‪0.56‬
50-Day Avg
‪25.31‬
200-Day Avg
‪26.05‬
Dividends
Payout Ratio
‪43.09%‬
Frequency
Quarterly
Market Cap - 0Q1N - Pfizer Inc.
Peers - 0Q1N - Pfizer Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on LSE.
- 0Q1NLSEPfizer Inc.170.06BMarket Cap+10.79%52-week change6.27P/E (Trailing)‪27.55%‬Profit Margin
- AZNLSEAstraZeneca PLC18.78TMarket Cap+1.97%52-week change24.98P/E (Trailing)‪17.02%‬Profit Margin
- GSKLSEGSK plc7.57TMarket Cap+21.75%52-week change16.11P/E (Trailing)‪14.52%‬Profit Margin
- 0QIULSENovo Nordisk A/S1.27TMarket Cap-16.46%52-week change19.95P/E (Trailing)‪33.39%‬Profit Margin
- 0Q1GLSEEli Lilly and Company1.02TMarket Cap+54.90%52-week change1.56P/E (Trailing)‪33.52%‬Profit Margin
- 0QCVLSEAbbVie Inc.478.52BMarket Cap+22.12%52-week change54.73P/E (Trailing)‪15.50%‬Profit Margin
- 0QAHLSEMerck & Co., Inc.385.67BMarket Cap+44.02%52-week change63.23P/E (Trailing)‪5.33%‬Profit Margin
Profile Summary - 0Q1N - Pfizer Inc.
About
Pfizer Inc. is a leading biopharmaceutical company that discovers, develops, manufactures, markets, distributes, and sells prescription drugs and vaccines worldwide. Operating in segments including Biopharma, PC1, and Pfizer Ignite, it focuses on key therapeutic areas such as oncology, cardiology, immunology, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
